Vyant Bio, Inc.
VYNT · NASDAQ
12/31/2022 | 9/30/2022 | 6/30/2022 | 3/31/2022 | |
|---|---|---|---|---|
| Revenue | $46 | $152 | $165 | $303 |
| % Growth | -69.7% | -7.9% | -45.5% | – |
| Cost of Goods Sold | $61 | $257 | $304 | $386 |
| Gross Profit | -$15 | -$105 | -$139 | -$83 |
| % Margin | -32.6% | -69.1% | -84.2% | -27.4% |
| R&D Expenses | $1,540 | $1,993 | $1,688 | $1,551 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $1,943 | $1,583 | $2,509 | $2,763 |
| Sales & Mktg Exp. | $1,943 | $1,583 | $0 | $0 |
| Other Operating Expenses | $0 | $5 | $0 | $0 |
| Operating Expenses | $3,483 | $3,576 | $4,197 | $4,314 |
| Operating Income | -$3,498 | -$3,681 | -$4,336 | -$4,397 |
| % Margin | -7,604.3% | -2,421.7% | -2,627.9% | -1,451.2% |
| Other Income/Exp. Net | $69 | $34 | $11 | -$9 |
| Pre-Tax Income | -$3,429 | -$3,647 | -$4,325 | -$4,406 |
| Tax Expense | $6,883 | -$218 | $1,469 | $4,766 |
| Net Income | -$10,312 | -$3,429 | -$5,794 | -$9,172 |
| % Margin | -22,417.4% | -2,255.9% | -3,511.5% | -3,027.1% |
| EPS | -1.75 | -0.58 | -0.98 | -1.58 |
| % Growth | -201.7% | 40.8% | 38% | – |
| EPS Diluted | -1.75 | -0.58 | -0.98 | -1.58 |
| Weighted Avg Shares Out | 5,904 | 5,883 | 5,883 | 5,803 |
| Weighted Avg Shares Out Dil | 5,904 | 5,883 | 5,883 | 5,803 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $64 | $29 | $11 | $9 |
| Depreciation & Amortization | $198 | $198 | $207 | $240 |
| EBITDA | -$3,167 | -$3,420 | -$4,107 | -$4,157 |
| % Margin | -6,884.8% | -2,250% | -2,489.1% | -1,371.9% |